Does serum 25‑hydroxyvitamin D (25‑OH D) reflect vitamin D2 (ergocalciferol), vitamin D3 (cholecalciferol), or both?

Serum 25-OH D Reflects Both Vitamin D2 and D3

Serum 25-hydroxyvitamin D [25(OH)D] measures both 25-hydroxyvitamin D2 (from ergocalciferol/vitamin D2) and 25-hydroxyvitamin D3 (from cholecalciferol/vitamin D3), and clinical laboratories should use assays that accurately quantify both forms to provide a complete assessment of vitamin D status 1.

Understanding What 25(OH)D Measures

The total serum 25(OH)D concentration represents the sum of two distinct metabolites:

• 25(OH)D3 - derived from vitamin D3 (cholecalciferol), which comes from both cutaneous synthesis via sun exposure and dietary/supplemental intake
• 25(OH)D2 - derived from vitamin D2 (ergocalciferol), which comes exclusively from dietary sources (certain mushrooms, fortified foods) or supplements

In most populations, 25(OH)D3 is the predominant form, typically comprising 67-83% of total 25(OH)D 2. However, this proportion varies based on supplementation patterns and dietary intake.

Critical Laboratory Considerations

Assay Selection Matters

Guidelines explicitly recommend choosing assays that measure both 25(OH)D2 and 25(OH)D3 1. This is particularly important because:

• Many immunoassays have unequal cross-reactivity for 25(OH)D2, leading to inaccurate results when significant amounts are present 3
• When substantial 25(OH)D2 is present, assays with poor D2 detection will report spuriously low total 25(OH)D levels 3
• Some assays don't measure 25(OH)D2 at all 3

When 25(OH)D2 Detection Becomes Critical

The presence of detectable 25(OH)D2 varies significantly:

• In general populations with minimal D2 supplementation: only 1.2% have detectable 25(OH)D2 4
• In populations using high-dose prescription vitamin D2: 19% have detectable levels, with 3% having concentrations >20 ng/mL 1, 5
• Primarily seen in adults aged ≥60 years taking prescription ergocalciferol (90th percentile: 17.3 nmol/L vs ≤4.88 nmol/L in younger groups) 5

Clinical Implications

For Routine Vitamin D Assessment

For patients not taking high-dose vitamin D2 supplements, standard 25(OH)D assays adequately reflect vitamin D status, as 25(OH)D3 predominates 2.

For Patients on Ergocalciferol

In patients receiving high-dose prescription vitamin D2 (ergocalciferol, typically 50,000 IU weekly), use liquid chromatography-tandem mass spectrometry (LC-MS/MS) that accurately quantifies both metabolites 3. This is essential because:

• Standard immunoassays may significantly underestimate total vitamin D status
• The reported value should be the sum of 25(OH)D2 + 25(OH)D3 1
• This particularly affects vegetarians and those with dietary restrictions who preferentially receive D2 6, 3

Geographic and Prescription Pattern Variations

In countries where vitamin D2 is the primary prescription form (e.g., Denmark and several European countries), the recommendation for dual-metabolite assays becomes even more critical 1. In the United States, both forms are available, but high-dose prescriptions are often ergocalciferol 7.

Practical Algorithm for Interpretation

When reviewing 25(OH)D results:

1. Verify the assay method - Does it measure both D2 and D3?
2. Check medication history - Is the patient taking prescription ergocalciferol (50,000 IU)?
3. If taking high-dose D2 AND using a standard immunoassay → Consider LC-MS/MS confirmation
4. If LC-MS/MS is used → Ensure the reported value is the sum of both metabolites
5. For vegetarians or those on D2 therapy → Preferentially use LC-MS/MS from the start

Quality Assurance

Laboratories should participate in external quality assessment schemes (e.g., DEQAS) that provide materials with documented commutability with human sera 1, 6. This ensures accurate measurement of both vitamin D metabolites across different analytical platforms.